{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:30:38Z","timestamp":1790353838412,"version":"4.1.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1093\/carcin\/bgs283","type":"journal-article","created":{"date-parts":[[2012,9,8]],"date-time":"2012-09-08T00:12:35Z","timestamp":1347063155000},"page":"2548-2557","source":"Crossref","is-referenced-by-count":42,"title":["Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B"],"prefix":"10.1093","volume":"33","author":[{"given":"Xiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janos","family":"Nadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Oi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana A.","family":"Zykova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hoon","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mee-Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung Ok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiya","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"Lubet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zigang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,9,8]]},"reference":[{"key":"key\n\t\t\t\t20170521015808_CIT0001","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1358\/dnp.2009.22.2.1343228","article-title":"The value of drug repositioning in the current pharmaceutical market.","volume":"22","author":"Tobinick","year":"2009","journal-title":"Drug News Perspect."},{"key":"key\n\t\t\t\t20170521015808_CIT0002","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/446975a","article-title":"When good drugs go bad.","volume":"446","year":"2007","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170521015808_CIT0003","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery.","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"key\n\t\t\t\t20170521015808_CIT0004","doi-asserted-by":"crossref","first-page":"11927","DOI":"10.1073\/pnas.0609752104","article-title":"Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs.","volume":"104","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20170521015808_CIT0005","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/0008-5472.CAN-03-3645","article-title":"Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity.","volume":"64","year":"2004","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521015808_CIT0006","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nsmb1265","article-title":"Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat.","volume":"14","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"key\n\t\t\t\t20170521015808_CIT0007","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1158\/0008-5472.CAN-06-1794","article-title":"Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells.","volume":"67","year":"2007","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521015808_CIT0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1289\/ehp.10403","article-title":"PI-3K\/Akt pathway-dependent cyclin D1 expression is responsible for arsenite-induced human keratinocyte transformation.","volume":"116","year":"2008","journal-title":"Environ. Health Perspect."},{"key":"key\n\t\t\t\t20170521015808_CIT0009","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1021\/jm800321h","article-title":"Synthesis of novel beta-lactone inhibitors of fatty acid synthase.","volume":"51","year":"2008","journal-title":"J. Med. Chem."},{"key":"key\n\t\t\t\t20170521015808_CIT0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jhm.8","article-title":"Effectiveness of ceftriaxone plus doxycycline in the treatment of patients hospitalized with community-acquired pneumonia.","volume":"1","year":"2006","journal-title":"J. Hosp. Med."},{"key":"key\n\t\t\t\t20170521015808_CIT0011","first-page":"35","article-title":"[Rocefin (ceftriaxone) in therapy of uncomplicated gonorrhea in males].","volume":"51","year":"2006","journal-title":"Antibiot. Khimioter."},{"key":"key\n\t\t\t\t20170521015808_CIT0012","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0140-6736(11)60580-1","article-title":"5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study.","volume":"377","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170521015808_CIT0013","doi-asserted-by":"crossref","first-page":"8062","DOI":"10.1021\/bi101167x","article-title":"Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations.","volume":"49","year":"2010","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170521015808_CIT0014","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbrc.2008.04.170","article-title":"Ceftiofur impairs pro-inflammatory cytokine secretion through the inhibition of the activation of NF-kappaB and MAPK.","volume":"372","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"key\n\t\t\t\t20170521015808_CIT0015","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance.","volume":"1773","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20170521015808_CIT0016","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc1503","article-title":"Targeting the mitogen-activated protein kinase cascade to treat cancer.","volume":"4","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20170521015808_CIT0017","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.chembiol.2008.04.013","article-title":"Molecular basis of drug resistance in aurora kinases.","volume":"15","year":"2008","journal-title":"Chem. Biol."},{"key":"key\n\t\t\t\t20170521015808_CIT0018","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.","volume":"49","year":"2006","journal-title":"J. Med. Chem."},{"key":"key\n\t\t\t\t20170521015808_CIT0019","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/AAC.23.4.583","article-title":"Clinical pharmacology of ceftriaxone in patients with neoplastic disease.","volume":"23","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"key":"key\n\t\t\t\t20170521015808_CIT0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0092-8674(74)90050-6","article-title":"Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium.","volume":"3","year":"1974","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170521015808_CIT0021","first-page":"361","article-title":"Molecular signaling regulating anchorage-independent growth of cancer cells.","volume":"71","author":"Wang","year":"2004","journal-title":"Mt. Sinai J. Med."},{"key":"key\n\t\t\t\t20170521015808_CIT0022","doi-asserted-by":"crossref","first-page":"11569","DOI":"10.1073\/pnas.181213498","article-title":"Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia.","volume":"98","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20170521015808_CIT0023","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJMra0802714","article-title":"Lung cancer.","volume":"359","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170521015808_CIT0024","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2174\/092986711794480203","article-title":"Aurora B: a new prognostic marker and therapeutic target in cancer.","volume":"18","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"key\n\t\t\t\t20170521015808_CIT0025","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/1535-7163.MCT-07-2051","article-title":"Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells.","volume":"7","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"key\n\t\t\t\t20170521015808_CIT0026","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/mc.20220","article-title":"The role of histone H3 phosphorylation (Ser10 and Ser28) in cell growth and cell transformation.","volume":"45","year":"2006","journal-title":"Mol. Carcinog."},{"key":"key\n\t\t\t\t20170521015808_CIT0027","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1210\/jc.2004-1518","article-title":"Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation.","volume":"90","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20170521015808_CIT0028","first-page":"4811","article-title":"Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells.","volume":"58","year":"1998","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521015808_CIT0029","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00428-009-0838-3","article-title":"Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients.","volume":"455","year":"2009","journal-title":"Virchows Arch."},{"key":"key\n\t\t\t\t20170521015808_CIT0030","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010.","volume":"60","year":"2010","journal-title":"CA. Cancer J. Clin."},{"key":"key\n\t\t\t\t20170521015808_CIT0031","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1188\/06.ONF.931-936","article-title":"Symptom clusters and quality of life in survivors of lung cancer.","volume":"33","year":"2006","journal-title":"Oncol. Nurs. Forum"},{"key":"key\n\t\t\t\t20170521015808_CIT0032","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S1470-2045(08)70255-9","article-title":"Lung infections after cancer chemotherapy.","volume":"9","year":"2008","journal-title":"Lancet Oncol."},{"key":"key\n\t\t\t\t20170521015808_CIT0033","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0962-8924(00)01880-8","article-title":"Chromosomal passengers and the (aurora) ABCs of mitosis.","volume":"11","year":"2001","journal-title":"Trends Cell Biol."},{"key":"key\n\t\t\t\t20170521015808_CIT0034","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.200208092","article-title":"The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint.","volume":"161","year":"2003","journal-title":"J. Cell Biol."},{"key":"key\n\t\t\t\t20170521015808_CIT0035","first-page":"296","article-title":"VX680\/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma.","volume":"2","year":"2010","journal-title":"Am. J. Transl. Res."},{"key":"key\n\t\t\t\t20170521015808_CIT0036","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/bjc.2011.21","article-title":"Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer.","volume":"104","year":"2011","journal-title":"Br. J. Cancer"},{"key":"key\n\t\t\t\t20170521015808_CIT0037","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1423-0127-19-9","article-title":"Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy.","volume":"19","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"key\n\t\t\t\t20170521015808_CIT0038","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1356-9597.2001.00498.x","article-title":"Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation.","volume":"7","year":"2002","journal-title":"Genes Cells"},{"key":"key\n\t\t\t\t20170521015808_CIT0039","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/pros.20345","article-title":"Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation.","volume":"66","year":"2006","journal-title":"Prostate"},{"issue":"5A","key":"key\n\t\t\t\t20170521015808_CIT0040","first-page":"3585","article-title":"Expression of Aurora-B kinase and phosphorylated histone H3 in hepatocellular carcinoma.","volume":"26","year":"2006","journal-title":"Anticancer Res."},{"key":"key\n\t\t\t\t20170521015808_CIT0041","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1158\/0008-5472.CAN-06-4705","article-title":"Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis.","volume":"67","year":"2007","journal-title":"Cancer Res."},{"issue":"12 Pt 1","key":"key\n\t\t\t\t20170521015808_CIT0042","first-page":"3158","article-title":"PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer.","volume":"6","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"key\n\t\t\t\t20170521015808_CIT0043","doi-asserted-by":"crossref","first-page":"9038","DOI":"10.1158\/0008-5472.CAN-05-0882","article-title":"The in vitro and in vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases.","volume":"65","year":"2005","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521015808_CIT0044","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s10637-011-9694-5","article-title":"Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152).","volume":"30","year":"2012","journal-title":"Invest. New Drugs"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/33\/12\/2548\/17290345\/bgs283.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T12:10:03Z","timestamp":1562155803000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgs283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,8]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,9,8]]},"published-print":{"date-parts":[[2012,12]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgs283","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9,8]]}}}